Showing results 1 to 30 of 31
Issue Date | Title | Author(s) |
---|---|---|
2022-06 | A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations | Kim, Seong A.; Kim, Seohyun; Kim, Gi Beom; Goo, Jiyoung; Kim, Nayeon; Lee, Yeram; Nam, Gi-Hoon; Lim, Seungho; Kim, Taeerk; Chang, Ki Hwan; Lee, Tae Gyu; Kim, In-San; Lee, Eun Jung |
2019-07 | An optimized protocol to determine the engulfment of cancer cells by phagocytes using flow cytometry and fluorescence microscopy | Nam, Gi-Hoon; Hong, Yeonsun; Choi, Yoonjeong; Kim, Gi Beom; Kim, Yoon Kyoung; Yang, Yoosoo; Kim, In-San |
2021-05 | Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity | Yang, Suah; Shim, Man Kyu; Kim, Woo Jun; Choi, Jiwoong; Nam, Gi-Hoon; Kim, Jeongrae; Kim, Jinseong; Moon, Yujeong; Kim, Han Young; Park, Jooho; Park, Yoon; Kim, In-San; Ryu, Ju Hee; Kim, Kwangmeyung |
2019-03 | Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer | Kim, In-San; Hong, Yeonsun; Nam, Gi-Hoon; Kim, Gi Beom |
2018-06 | Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer | Nam, Gi-Hoon; Lee, Eun Jung; Kim, Yoon Kyoung; Hong, Yeonsun; Choi, Yoonjeong; Ryu, Myung-Jeom; Woo, Jiwan; Cho, Yakdol; Ahn, Dong June; Yang, Yoosoo; Kwon, Ick-Chan; Park, Seung-Yoon; Kim, In-San |
2018-06-10 | Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics | Cho, Eunji; Nam, Gi-Hoon; Hong, Yeonsun; Kim, Yoon Kyoung; Kim, Dong-Hwee; Yang, Yoosoo; Kim, In-San |
2020-03 | Dendritic cell activation by an E. coli-derived monophosphoryl lipid A enhances the efficacy of PD-1 blockade | Jeong, Youngmin; Kim, Gi Beom; Ji, Yuhyun; Kwak, Gi-Jung; Nam, Gi-Hoon; Hong, Yeonsun; Kim, Seohyun; An, Jinsu; Kim, Sun Hwa; Yang, Yoosoo; Chung, Hak Suk; Kim, In-San |
2021-05-10 | Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation | Kim, Gi Beom; Sung, Hyo-Dong; Nam, Gi-Hoon; Kim, Wonjun; Kim, Seohyun; Kang, Dayeon; Lee, Eun Jung; Kim, In-San |
2020-12 | Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy | Nam, Gi-Hoon; Choi, Yoonjeong; Kim, Gi Beom; Kim, Seohyun; Kim, Seong A.; Kim, In-San |
2018-01-31 | Exosome as a Vehicle for Delivery of Membrane Protein Therapeutics, PH20, for Enhanced Tumor Penetration and Antitumor Efficacy | Hong, Yeonsun; Nam, Gi-Hoon; Koh, Eunee; Jeon, Sangmin; Kim, Gi Beom; Jeong, Cherlhyun; Kim, Dong-Hwee; Yang, Yoosoo; Kim, In-San |
2017-03 | Exosome-SIRP alpha, a CD47 blockade increases cancer cell phagocytosis | Koh, Eunee; Lee, Eun Jung; Nam, Gi-Hoon; Hong, Yeonsun; Cho, Eunji; Yang, Yoosoo; Kim, In-San |
2020-10-01 | Functionalized exosome harboring bioactive molecules for cancer therapy | Kim, Yoon Kyoung; Choi, Yoonjeong; Nam, Gi-Hoon; Kim, In-San |
2017-12 | Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy | Jo, Sung Duk; Nam, Gi-Hoon; Kwak, Gijung; Yang, Yoosoo; Kwon, Ick Chan |
2023-09 | Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy | Kim, Gi Beom; Kim, Seonghyun; Hwang, Yeong Ha; Kim, Seohyun; Lee, Inkyu; Kim, Seong A.; Goo, Jiyoung; Yang, Yoosoo; Jeong, Cherlhyun; Nam, Gi-Hoon; Kim, In-San |
2020-06 | Immunogenic clearance sensitizes cold tumor to PD-1 blockade by enhancing quantity and quality of CD8+T cells | Nam, Gi-Hoon; Choi, Yoonjeong; Kim, In-San |
2021-01 | In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis | Kim, Seohyun; Kim, Seong A.; Nam, Gi-Hoon; Hong, Yeonsun; Kim, Gi Beom; Choi, Yoonjeong; Lee, Seokyoung; Cho, Yuri; Kwon, Minsu; Jeong, Cherlhyun; Kim, Sehoon; Kim, In-San |
2019-11 | Intrinsic cancer vaccination | Yang, Yoosoo; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Yoon Kyoung; Kim, In-San |
2018-03-08 | Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer | Lee, Eun Jung; Nam, Gi-Hoon; Lee, Na Kyeong; Kih, Minwoo; Koh, Eunee; Kim, Yoon Kyoung; Hong, Yeonsun; Kim, Soyoun; Park, Seung-Yoon; Jeong, Cherlhyun; Yang, Yoosoo; Kim, In-San |
2021-09 | Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity | Choi, Yoonjeong; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Seohyun; Kim, Yoon Kyoung; Kim, Seong A.; Kim, Ha-Jeong; Lee, Eun Jung; Kim, In-San |
2024-07 | Novel insights into paclitaxel's role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment | Choi, Yoonjeong; Kim, Seong A.; Jung, Hanul; Kim, Eunhae; Kim, Yoon Kyoung; Kim, Seohyun; Kim, Jaehyun; Lee, Yeji; Jo, Min Kyoung; Woo, Jiwan; Cho, Yakdol; Lee, Dongjoo; Choi, Hongyoon; Jeong, Cherlhyun; Nam, Gi-Hoon; Kwon, Minsu; Kim, In-San |
2024-07 | Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity | Han, Jihoon; Kim, Seohyun; Hwang, Yeong Ha; Kim, Seong A.; Lee, Yeji; Kim, Jihong; Cho, Seongeon; Woo, Jiwan; Jeong, Cherlhyun; Kwon, Minsu; Nam, Gi-Hoon; Kim, In-San |
2021-03-10 | Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages | Je, Hyeonwoo; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Wonjun; Kim, Soo Rin; Kim, In-San; Lee, Eun Jung |
2023-01 | Protein-based nanocages for vaccine development | Kim, Seong A.; Lee, Yeram; Ko, Yeju; Kim, Seohyun; Kim, Gi Beom; Lee, Na Kyeong; Ahn, Wonkyung; Kim, Nayeon; Nam, Gi-Hoon; Lee, Eun Jung; Kim, In-San |
2023-02 | Small Extracellular Vesicles as a New Class of Medicines | Lee, Inkyu; Choi, Yoonjeong; Shin, Dong-U; Kwon, Minjeong; Kim, Seohyun; Jung, Hanul; Nam, Gi-Hoon; Kwon, Minsu |
2021-12-01 | Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma | Kwon, Minsu; Nam, Gi-Hoon; Jung, Hanul; Kim, Seong A.; Kim, Seohyun; Choi, Yeonju; Lee, Yoon Se; Cho, Hyo Jung; Kim, In-San |
2021-07 | Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer | Nam, Gi-Hoon; Kwon, Minsu; Jung, Hanul; Ko, Eunbyeol; Kim, Seong A.; Choi, Yoonjeong; Song, Su Jeong; Kim, Seohyun; Lee, Yeji; Kim, Gi Beom; Han, Jihoon; Woo, Jiwan; Cho, Yakdol; Jeong, Cherlhyun; Park, Seung-Yoon; Roberts, Thomas M.; Cho, Yong Beom; Kim, In-San |
2024-06 | The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex | Kim, Sang Hoon; Lee, Bo Ryeong; Kim, Sung-Min; Kim, Sungsik; Kim, Min-seok; Kim, Jaehyun; Lee, Inkyu; Kim, Hee-Soo; Nam, Gi-Hoon; Kim, In-San; Song, Kyuyoung; Choi, Yoonjoo; Lee, Dong-Sup; Park, Woong-Yang |
2021-03-10 | The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy | Kwon, Minsu; Jung, Hanul; Nam, Gi-Hoon; Kim, In-San |
2017-04-04 | Virus-Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes | Yang, Yoosoo; Hong, Yeonsun; Nam, Gi-Hoon; Chung, Jin Hwa; Koh, Eunee; Kim, In-San |
2020-07 | Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity | Kim, Gi Beom; Nam, Gi-Hoon; Hong, Yeonsun; Woo, Jiwan; Cho, Yakdol; Kwon, Ick Chan; Yang, Yoosoo; Kim, In-San |